×
About 5,990 results

ALLMedicine™ Retinal Vein Occlusion Center

Research & Reviews  2,875 results

Tractional retinal detachment ('crunch' phenomenon) from intravitreal anti-vascular end...
https://doi.org/10.1136/bcr-2020-240506
BMJ Case Reports; Bromeo AJ, Veloso A et. al.

Apr 29th, 2021 - Tractional retinal detachment is an uncommon complication of intravitreal anti-vascular endothelial growth factor (VEGF) injection wherein the drug triggers tractional retinal detachment as a result of fibrovascular membrane contraction. We presen...

Central retinal vein occlusion and compressive optic neuropathy secondary to thyroid ey...
https://doi.org/10.1017/cjn.2021.85
The Canadian Journal of Neurological Sciences. Le Journal... Jeeva-Patel T, Emami S et. al.

Apr 29th, 2021 - Central retinal vein occlusion and compressive optic neuropathy secondary to thyroid eye disease.|2021|Jeeva-Patel T,Emami S,Margolin E,|

Monitoring Dynamic Growth of Retinal Vessels in Oxygen-Induced Retinopathy Mouse Model.
https://doi.org/10.3791/62410
Journal of Visualized Experiments : JoVE; Ma Y, Li T

Apr 19th, 2021 - Oxygen-induced retinopathy (OIR) is widely used to study abnormal vessel growth in ischemic retinal diseases, including retinopathy of prematurity (ROP), proliferative diabetic retinopathy (PDR), and retinal vein occlusion (RVO). Most OIR studies ...

Asymptomatic Retinal Vein Occlusion in a 13-Year-Old With Heterozygous Deletion of the ...
https://doi.org/10.1097/WNO.0000000000001233
Journal of Neuro-ophthalmology : the Official Journal of ... Saffra NA, Emborgo TS et. al.

Apr 19th, 2021 - Asymptomatic Retinal Vein Occlusion in a 13-Year-Old With Heterozygous Deletion of the PMP22 Gene and a Diagnosis of Hereditary Neuropathy With Liability to Pressure Palsies.|2021|Saffra NA,Emborgo TS,Laureta EC,Kirsch DS,Guarini L,|

The Structural and Comparative Analysis of Intravitreal Dexamethasone Implant (Ozurdex)...
https://doi.org/10.1080/08820538.2021.1890146
Seminars in Ophthalmology; Park JH, Kim EC

Apr 12th, 2021 - Background and Objective: To evaluate and compare the structural changes of retinal vasculature after intravitreal dexamethasone implant (Ozurdex) insertion and antivascular endothelial growth factor (anti-VEGF) injection in patients with branched...

see more →

Guidelines  1 results

Therapies for Macular Edema Associated with Branch Retinal Vein Occlusion: A Report by the A...
https://www.aaojournal.org/article/S0161-6420(17)30980-6/fulltext
Justis P. Ehlers

Aug 31st, 2017 - Current level I evidence suggests that intravitreal pharmacotherapy with anti-VEGF agents is effective and safe for ME secondary to BRVO. Prolonged delay in treatment is associated with less improvement in visual acuity (VA).

see more →

Drugs  4 results see all →

Clinicaltrials.gov  2,999 results

Tractional retinal detachment ('crunch' phenomenon) from intravitreal anti-vascular end...
https://doi.org/10.1136/bcr-2020-240506
BMJ Case Reports; Bromeo AJ, Veloso A et. al.

Apr 29th, 2021 - Tractional retinal detachment is an uncommon complication of intravitreal anti-vascular endothelial growth factor (VEGF) injection wherein the drug triggers tractional retinal detachment as a result of fibrovascular membrane contraction. We presen...

Central retinal vein occlusion and compressive optic neuropathy secondary to thyroid ey...
https://doi.org/10.1017/cjn.2021.85
The Canadian Journal of Neurological Sciences. Le Journal... Jeeva-Patel T, Emami S et. al.

Apr 29th, 2021 - Central retinal vein occlusion and compressive optic neuropathy secondary to thyroid eye disease.|2021|Jeeva-Patel T,Emami S,Margolin E,|

Monitoring Dynamic Growth of Retinal Vessels in Oxygen-Induced Retinopathy Mouse Model.
https://doi.org/10.3791/62410
Journal of Visualized Experiments : JoVE; Ma Y, Li T

Apr 19th, 2021 - Oxygen-induced retinopathy (OIR) is widely used to study abnormal vessel growth in ischemic retinal diseases, including retinopathy of prematurity (ROP), proliferative diabetic retinopathy (PDR), and retinal vein occlusion (RVO). Most OIR studies ...

Asymptomatic Retinal Vein Occlusion in a 13-Year-Old With Heterozygous Deletion of the ...
https://doi.org/10.1097/WNO.0000000000001233
Journal of Neuro-ophthalmology : the Official Journal of ... Saffra NA, Emborgo TS et. al.

Apr 19th, 2021 - Asymptomatic Retinal Vein Occlusion in a 13-Year-Old With Heterozygous Deletion of the PMP22 Gene and a Diagnosis of Hereditary Neuropathy With Liability to Pressure Palsies.|2021|Saffra NA,Emborgo TS,Laureta EC,Kirsch DS,Guarini L,|

The Structural and Comparative Analysis of Intravitreal Dexamethasone Implant (Ozurdex)...
https://doi.org/10.1080/08820538.2021.1890146
Seminars in Ophthalmology; Park JH, Kim EC

Apr 12th, 2021 - Background and Objective: To evaluate and compare the structural changes of retinal vasculature after intravitreal dexamethasone implant (Ozurdex) insertion and antivascular endothelial growth factor (anti-VEGF) injection in patients with branched...

see more →

News  109 results

Retinal Vein Occlusion Clinical Practice Guidelines (2019)
https://reference.medscape.com/viewarticle/917394

Sep 2nd, 2019 - In August 2019, the European Society of Retina Specialists (EURETINA) published clinical practice guidelines on the management of retinal vein occlusion (RVO).[1] Patients with suspected retinal vein occlusion (RVO) should undergo a full ophthalmo...

FDA Okays Aflibercept (Eylea) for Diabetic Retinopathy
https://www.staging.medscape.com/viewarticle/913006

May 13th, 2019 - The US Food and Drug Administration (FDA) has approved aflibercept (Eylea, Regeneron Pharmaceuticals) injection solution to treat all stages of diabetic retinopathy, the manufacturer has announced. Aflibercept, a vascular endothelial growth factor...

FDA OKs Aflibercept (Eylea) for Diabetic Retinopathy
https://www.medscape.com/viewarticle/913006

May 13th, 2019 - The US Food and Drug Administration (FDA) has approved aflibercept (Eylea, Regeneron) injection solution to treat all stages of diabetic retinopathy, the manufacturer has announced. Aflibercept, a vascular endothelial growth factor (VEGF) inhibito...

Anti-VEGF Tx Seems OK for Eye Disorders
https://www.medpagetoday.com/ophthalmology/generalophthalmology/71990

Mar 25th, 2018 - Intravitreal anti-VEGF treatments for neovascular age-related macular degeneration (AMD), diabetic macular edema (DME), or retinal vein occlusion did not appear to increase the risk of systemic adverse events, particularly cardiovascular adverse e...

A Guide To Managing RVO: Ophthalmology Times
https://www.medpagetoday.com/ophthalmology/generalophthalmology/70255

Jan 2nd, 2018 - One expert discusses options for managing retinal vein occlusion over the long-term in patients with macular edema. A recent study reported that visual acuity did not improve when patients with diabetic macular edema received corticosteroid implan...

see more →

Patient Education  2 results see all →